Overview

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)

Status:
Unknown status
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of SB injection in Hepatocellular Carcinoma (HCC).
Phase:
Phase 2
Details
Lead Sponsor:
SBPharmaceutical IND, Co., LTD